|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-1-21
|
|
pubmed:abstractText |
Isoflavonoids are discussed for use in chemoprevention and treatment of prostate cancer. We investigated the potential of genistein to modulate androgen receptor (AR) expression and transcriptional activity in the human androgen-sensitive prostate cancer cell line LNCaP.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
245-51; discussion 251
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14734014-Antineoplastic Agents,
pubmed-meshheading:14734014-Down-Regulation,
pubmed-meshheading:14734014-Estrogen Receptor beta,
pubmed-meshheading:14734014-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:14734014-Genistein,
pubmed-meshheading:14734014-Humans,
pubmed-meshheading:14734014-Male,
pubmed-meshheading:14734014-Prostate-Specific Antigen,
pubmed-meshheading:14734014-Prostatic Neoplasms,
pubmed-meshheading:14734014-Receptors, Androgen,
pubmed-meshheading:14734014-Receptors, Estrogen,
pubmed-meshheading:14734014-Tumor Cells, Cultured
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta.
|
|
pubmed:affiliation |
Department of Urology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
